Delivery Order SPE2DR25D9239-SPE2DR26FFBW5
Award Date 1/14/26
Potential Completion Date 2/5/26
Potential Value $2.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,083.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Lucentis 0.5 mg/0.05 mL syringes. This firm fixed-price delivery order, issued on October 29, 2025, with an ultimate completion date of November 20, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,460.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lucentis 0.5 mg/0.05 mL. This firm fixed-price delivery order, issued on December 23, 2025, with an ultimate completion date of December 24, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS...
- The Defense Logistics Agency awarded a delivery order valued at $1,639.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lucentis 0.5 mg/0.05 ml syringes. This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of December 4, 2025, carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The order...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $5,059.60 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for 0.3 mg/0.05 mL syringes of Lucentis, a branded ophthalmic pharmaceutical product. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB24FB3JY, with a ceiling of up to $4,999,999 that enables DLA to issue delivery orders for a variety of...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,345.48 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lucentis 0.5 mg/0.05 mL. This delivery order, issued without a set-aside designation, is scheduled for completion by November 21, 2025, and represents a routine pharmaceutical procurement to support Department of Defense medical supply needs. DMS Pharmaceutical Group...
- This firm-fixed-price delivery order, valued at $3,035.76, was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue delivery orders for a comprehensive range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,861.10, is for the delivery of LUCENTIS 0.5 MG/0.05 ML SYRING 0.05ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a performance period through May 29, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on April 28, 2025, for Lucentis 0.3 mg/0.05 ml syringes. The contract carries a ceiling value of $1,937.40 under a firm fixed-price delivery order structure with an ultimate completion date of May 19, 2025. This award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete on its...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,088.88 contract will provide LUCENTIS 0.5 MG/0.05 ML SYRING 0.05ML medical supplies to support the recurring pharmaceutical needs of military health facilities under the DLA's Medical Supply Chain division. This delivery order is part of a larger $499,999,999 indefinite delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,544.44 firm fixed-price delivery order is for the supply of LUCENTIS 0.5 MG/0.05 ML syringes, with a completion date of October 8, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...